Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Arra

Showing results (31-40 of 143) with videos related to

Pageof 15
Sort By:
BMC Cancer|March 6, 2017
miR-155 is positively regulated by CBX7 in mouse embryonic fibroblasts and colon carcinomas, and targets the KRAS oncogeneFloriana Forzati, Marco De Martino, Francesco Esposito, et al.
In Vivo (Athens, Greece)|April 28, 2019
Naloxone Counteracts the Promoting Tumor Growth Effects Induced by Morphine in an Animal Model of Triple-negative Breast CancerSabrina Bimonte, Antonio Barbieri, Marco Cascella, et al.
Plos One|October 3, 2012
Adoptive immunotherapy with Cl-IB-MECA-treated CD8+ T cells reduces melanoma growth in miceAntonella Montinaro, Giovanni Forte, Rosalinda Sorrentino, et al.
Chemmedchem|January 3, 2008
Peptide-containing aggregates as selective nanocarriers for therapeuticsAntonella Accardo, Diego Tesauro, Luigi Aloj, et al.
Oncotarget|September 21, 2015
Triple negative breast cancer: looking for the missing link between biology and treatmentsGiuseppe Palma, Giuseppe Frasci, Andrea Chirico, et al.
International Journal of Pharmaceutics|July 4, 2014
Antitumor activity of PEGylated biodegradable nanoparticles for sustained release of docetaxel in triple-negative breast cancerGiuseppe Palma, Claudia Conte, Antonio Barbieri, et al.
Journal of Cellular Physiology|August 14, 2012
Embryonic defects and growth alteration in mice with homozygous disruption of the Patz1 geneTeresa Valentino, Dario Palmieri, Michela Vitiello, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|September 6, 2011
Core-shell biodegradable nanoassemblies for the passive targeting of docetaxel: features, antiproliferative activity and in vivo toxicityFrancesca Ungaro, Claudia Conte, Luisanna Ostacolo, et al.
Cancer Research|August 18, 2004
Identification of the genes up- and down-regulated by the high mobility group A1 (HMGA1) proteins: tissue specificity of the HMGA1-dependent gene regulationJosefina Martinez Hoyos, Monica Fedele, Sabrina Battista, et al.
Frontiers in Cell and Developmental Biology|April 26, 2021
The Transcription Regulator Patz1 Is Essential for Neural Stem Cell Maintenance and ProliferationSara Mancinelli, Michela Vitiello, Maria Donnini, et al.
Pageof 15

Showing results (31-40 of 143) with videos related to

Sort By:
Pageof 15
BMC Cancer|March 6, 2017
miR-155 is positively regulated by CBX7 in mouse embryonic fibroblasts and colon carcinomas, and targets the KRAS oncogeneFloriana Forzati, Marco De Martino, Francesco Esposito, et al.
In Vivo (Athens, Greece)|April 28, 2019
Naloxone Counteracts the Promoting Tumor Growth Effects Induced by Morphine in an Animal Model of Triple-negative Breast CancerSabrina Bimonte, Antonio Barbieri, Marco Cascella, et al.
Plos One|October 3, 2012
Adoptive immunotherapy with Cl-IB-MECA-treated CD8+ T cells reduces melanoma growth in miceAntonella Montinaro, Giovanni Forte, Rosalinda Sorrentino, et al.
Chemmedchem|January 3, 2008
Peptide-containing aggregates as selective nanocarriers for therapeuticsAntonella Accardo, Diego Tesauro, Luigi Aloj, et al.
Oncotarget|September 21, 2015
Triple negative breast cancer: looking for the missing link between biology and treatmentsGiuseppe Palma, Giuseppe Frasci, Andrea Chirico, et al.
International Journal of Pharmaceutics|July 4, 2014
Antitumor activity of PEGylated biodegradable nanoparticles for sustained release of docetaxel in triple-negative breast cancerGiuseppe Palma, Claudia Conte, Antonio Barbieri, et al.
Journal of Cellular Physiology|August 14, 2012
Embryonic defects and growth alteration in mice with homozygous disruption of the Patz1 geneTeresa Valentino, Dario Palmieri, Michela Vitiello, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|September 6, 2011
Core-shell biodegradable nanoassemblies for the passive targeting of docetaxel: features, antiproliferative activity and in vivo toxicityFrancesca Ungaro, Claudia Conte, Luisanna Ostacolo, et al.
Cancer Research|August 18, 2004
Identification of the genes up- and down-regulated by the high mobility group A1 (HMGA1) proteins: tissue specificity of the HMGA1-dependent gene regulationJosefina Martinez Hoyos, Monica Fedele, Sabrina Battista, et al.
Frontiers in Cell and Developmental Biology|April 26, 2021
The Transcription Regulator Patz1 Is Essential for Neural Stem Cell Maintenance and ProliferationSara Mancinelli, Michela Vitiello, Maria Donnini, et al.
Pageof 15